ERBB3 and non-small cell lung carcinoma: Activation of ERBB3 heterodimers by HRG in negative-EML4-ALK NSCLC cell line treated with either ERL or in combination with LOR had a minimal impact on cell viability with similar IC50 values (Supplementary Fig. S11A).